13 August 2024
13 August 2024
Astria Therapeutics plans to deploy hereditary angioedema (HAE) candidate STAR-0215 using Ypsomed’s Ypsomate autoinjector.
Inclusion into the STeP programme means the device will receive expedited approval from the FDA as the company prepares for market.
The Masimo W1 medical watch, together with the Masimo SafetyNet solution, allows clinicians to monitor patient data remotely.
The collaboration aims to enhance the analysis of cardiac and spine disease imaging and treatment using AI technology.
Stryker is continuing its M&A spree after CEO told investors to expect a “very active deal pipeline” for the second half of 2024.
The blood test can measure the levels of neurofilament, a brain health biomarker, in the blood.
The collaboration introduces Darby Dispatch platform to assist dental practices in managing their service requests.
Spectral is already making plans for post FDA-approval, partnering with Baxter for commercialisation duties.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
